Envestnet Asset Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Envestnet Asset Management Inc

$281 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$144.95 - $152.29 $4.35 Million - $4.57 Million	-30,030 Reduced 90.44%	3,174 $480,000
Q2 2022 Aug 03, 2022	BUY	$83.14 - $145.99 $278,934 - $489,796	3,355 Added 11.24%	33,204 $4.84 Million
Q1 2022 May 04, 2022	BUY	$110.08 - $142.92 $363,814 - $472,350	3,305 Added 12.45%	29,849 $3.54 Million
Q4 2021 Feb 04, 2022	BUY	$99.73 - $148.48 $2.19 Million - $3.26 Million	21,925 Added 474.67%	26,544 $3.66 Million
Q3 2021 Oct 07, 2021	BUY	$98.85 - $138.91 $84,615 - $118,906	856 Added 22.75%	4,619 $642,000
Q2 2021 Aug 04, 2021	BUY	$65.78 - $105.02 $19,339 - $30,875	294 Added 8.48%	3,763 $365,000
Q1 2021 May 04, 2021	BUY	$64.07 - $91.75 $49,718 - $71,198	776 Added 28.82%	3,469 $237,000
Q4 2020 Feb 02, 2021	BUY	$65.07 - $98.24 $175,233 - $264,560	2,693 New	2,693 $231,000
Q3 2020 Oct 09, 2020	SELL	$59.04 - $77.95 $208,706 - $275,553	-3,535 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$29.01 - $74.23 $102,550 - $262,403	3,535 New	3,535 $258,000
Q2 2019 Aug 02, 2019	SELL	$39.79 - $67.01 $154,265 - $259,797	-3,877 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $133,834 - $206,605	3,877 New	3,877 $200,000
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $40,200 - $52,718	-1,226 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$23.62 - $42.29 $3,306 - $5,920	140 Added 12.89%	1,226 $48,000
Q1 2018 May 09, 2018	BUY	$22.49 - $34.56 $12,414 - $19,077	552 Added 103.37%	1,086 $28,000
Q4 2017 Feb 20, 2018	SELL	$20.44 - $35.56 $11,425 - $19,878	-559 Reduced 51.14%	534 $14,000
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $2,448 - $3,973	104 Added 10.52%	1,093 $41,000
Q2 2017 Aug 14, 2017	BUY	N/A	989	989 $25,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account